Amplatzer™ Vascular Plug 4 (REF 9-AVP038-006)Recalls & reported problems
Aga Medical Corporation · Vascular Plug 4 · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00811806012360), received between Jun 16, 2023 and Dec 5, 2023 — classified as 2 injuries.
The most frequently reported specific device problem is “Difficult to Fold, Unfold or Collapse” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Fold, Unfold or Collapse1
- Fracture1
- Improper or Incorrect Procedure or Method1
- Migration or Expulsion of Device1
- Off-Label Use1
- Separation Problem1
Patient problems
- Foreign Body In Patient1
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryDec 5, 2023Migration or Expulsion of Device; Off-Label Use; Migration or Expulsion of Device; Off-Label Use
THE ARTICLE, ¿RISK FACTORS ASSOCIATED WITH DEVICE EMBOLISATION OR MALPOSITION DURING TRANSCATHETER CLOSURE OF PATENT DUCTUS ARTERIOSUS¿, WAS REVIEWED. THE ARTICLE PRESENTED A CASE STUDY OF A 1 MONTH OLD PATIENT WEIGHING 2.1 KG THAT WAS BORN PRE-TERM. IT WAS REPORTED THAT ON AN UNKNOWN DATE, A 6MM AMPLATZER VASCULAR PLUG IV WAS CHOSEN FOR IMPLANT TO TREAT PATENT DUCTUS ARTERIOSUS (PDA) THAT WAS SIZED 4 MM. IT WAS THEN REPORTED ON AN UNKNOWN DATE, THE DEVICE HAD EMBOLIZED AND A DECISION WAS MADE TO RETRIEVE THE DEVICE VIA TRANSCATHETER SNARE AND REPLACE WITH AN 8MM AMPLATZER VASCULAR PLUG II. AFTER INTERVENTION PROCEDURE, IT WAS REPORTED THE PATIENT DEVELOPED LEFT PULMONARY STENOSIS. THE ARTICLE CONCLUDED DEVICE EMBOLISATION COMPLICATES 4% OF TRANSCATHETER DUCT CLOSURES, WITH NEED FOR SURGERY IN ONE-FIFTH OF THEM. LARGER DUCTS WITH HIGH PULMONARY ARTERY PRESSURES IN YOUNGER AND SMALLER INFANTS ARE MORE OFTEN ASSOCIATED WITH DEVICE EMBOLISATION. TUBULAR DUCTS ARE MORE PRONE FOR EMBOLISATION COMPARED TO USUAL CONICAL DUCTS. SOFTER VASCULAR PLUGS ARE OFTEN ASSOCIATED WITH EMBOLISATIONS. INTENTIONAL DEVICE UNDERSIZING TO AVOID VASCULAR OBSTRUCTION IN SMALL PATIENTS IS A FREQUENT RISK FAC
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18268497 ↗InjuryJun 16, 2023Difficult to Fold, Unfold or Collapse; Fracture; Improper or Incorrect Procedure or Method; Separation Problem; Difficult to Fold, Unfold or Collapse; Fracture; Improper or Incorrect Procedure or Method; Separation Problem
IT WAS REPORTED THAT ON (B)(6) 2023, A 6MM AMPLATZER VASCULAR PLUG IV WAS SELECTED FOR AN IMPLANT. DURING THE PROCEDURE, THERE WAS ISSUE WITH THE PLUG. IT WAS IMPOSSIBLE TO DETACH THE PLUG AND IMPOSSIBLE TO RETRACT THE PLUG AFTER DEPLOYMENT IN THE LEFT GONADAL VEIN. THE DELIVERY WIRE WAS LEFT IN PLACE (LEFT GONADAL VEIN, LEFT RENAL VEIN, LEFT CAVE VEIN, RIGHT ILIAC VEIN AND RIGHT COMMON FEMORAL VEIN) AND SECURED IN THE RIGHT ILIAC VEIN WITH A STENT TO LIMIT RISK OF SECONDARY MIGRATION. THE PATIENT DID NOT HAVE A TORTUOUS ANATOMY. THE PLUG WAS NOT DEFORMED/DAMAGED/ DURING PROCEDURE. AN ANTIAGGREGANT TREATMENT WILL BE APPLIED TO THE PATIENT FOR 6 MONTHS POST PROCEDURE TO LIMIT THE RISK OF VENOUS THROMBOSIS AT THE RENAL VEIN, RISK OF COMPLICATION AT THE LOWER MEMBER, RISK OF MIGRATION IN THE HEART. THE PROCEDURE TIME WAS EXTENDED TO A TOTAL TIME OF 3 HOURS. PATIENT STATUS WAS REPORTED AS STABLE. NO ADDITIONAL INFORMATION PROVIDED. ON 18 AUGUST 2023, ADDITIONAL INFORMATION RECEIVED; THE PLUG REMAINED IMPLANTED AT THE TARGET LESION AND REMAINED ATTACHED TO THE DISTAL PART OF THE CABLE. PART OF THE CABLE WITH THE PLUG AND LEFT IN THE PATIENT. THE CABLE IS MAINTAINED BY THE PLUG DISTALLY
Patient problems: Foreign Body In Patient; Insufficient Information
MAUDE report 17148744 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page